The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.
A board-certified sleep medicine specialist reviews the history of wearable sleep trackers and explains how clinicians ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
The treatment has become increasingly popular, especially among older men. Here is what to keep in mind if you are ...
Discover the link between REM sleep and Alzheimer's disease. Learn how delayed REM sleep may indicate elevated protein levels ...
There’s no question that sleep is important for your health. Without enough of it, your risk of developing diseases such as ...
Dr Amir Khan has warned over a condition that affects one in five Brits - and can be caused by a range of factors with very ...
Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...